UroGen

URGN · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings 29 days ago

Total Revenue

$37.8M

Previous year: $24.6M

Previous year: $14.9M

-3.9%

SG&A Expenses

$39.3M

Previous year: $34.9M

+12.9%

Activated Sites of Care

838

Gross Profit

$34.5M

Previous year: $22.1M

Loading...

UroGen

Unlock previous datapoints

Upgrade

UroGen

Unlock previous datapoints

Upgrade

UroGen Revenue by Segment

UroGen Revenue by Geographic Location

Revenue by Segment

JELMYTO Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

ZUSDURI Revenue

CapyFin.com

Revenue by Geographic Location

United States Revenue

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$836M

P/E Ratio

-6.12

Sector

N/A

Industry

N/A

52-Week High

$29.3

52-Week Low

$3.93

R&D Expenses

$14.3M

SG&A Expenses

$39.3M

Activated Sites of Care

838

Unique ZUSDURI Prescribers

102

Products

Get in Touch

Resources

UroGen

UroGen

UroGen

UroGen Revenue by Segment

UroGen Revenue by Geographic Location

Revenue by Segment

JELMYTO Revenue

ZUSDURI Revenue

Revenue by Geographic Location

United States Revenue

Revenue & Expenses

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics